Skip to main content
Clinical Trials/NCT03493711
NCT03493711
Completed
Not Applicable

Microbiota Differences Between Breastfed and Formula Fed Infants

Arkansas Children's Hospital Research Institute1 site in 1 country158 target enrollmentFebruary 21, 2018
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
Arkansas Children's Hospital Research Institute
Enrollment
158
Locations
1
Primary Endpoint
The role of microbiota in immune system development
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study will help us learn how a child's diet affects growth and development.

Detailed Description

This study will see how infants diet affects their growth and development. Up to 170 infants will be enrolled for one visit.

Registry
clinicaltrials.gov
Start Date
February 21, 2018
End Date
August 6, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Exclusive breast feeding or cow milk formula feeding during the first 3 months of life.
  • For formula feeders, exclusively on Similac Advance Formula for at least 1 month prior to visit
  • Age 2.5-3.5 months

Exclusion Criteria

  • Infants born to mother with preexisting medical conditions.
  • Infants born to mother with medications during pregnancy known to influence fetal growth.
  • Infants born to smoking, alcohol drinking or drug use mothers during pregnancy.

Outcomes

Primary Outcomes

The role of microbiota in immune system development

Time Frame: 2.5-3 months

Stool samples will be collected

The role of microbiota in gut

Time Frame: 2.5-3 months

Stool samples will be collected

Study Sites (1)

Loading locations...

Similar Trials